Upstream Bio, Inc. (UPB) vs Yarrow Bioscience, Inc (YARW)
- Upstream Bio, Inc. UPB 2.76 −18.10%
- Yarrow Bioscience, Inc YARW 18.78 −6.10%
Upstream Bio, Inc. and Yarrow Bioscience, Inc are both Biotechnology companies. Upstream Bio, Inc. and Yarrow Bioscience, Inc are of similar size ($188.8M and $184.6M). Upstream Bio, Inc. grew revenue faster over the last twelve months: 16.0% against 1.26%. Yarrow Bioscience, Inc has the higher net margin (−3,881.5% vs −4,955.7%) and the higher return on invested capital (0.00% vs −1,100.9%). Across the 15 metrics below, Upstream Bio, Inc. leads on 9 and Yarrow Bioscience, Inc on 6.
Valuation
Profitability
| Metric | UPB | YARW | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (5,382.65%) | (4,134.44%) | 0.00% |
| Net margin | (4,955.67%) | (3,881.54%) | 0.00% |
| Free cash flow margin | (4,317.42%) | (3,513.07%) | 0.00% |
| Return on equity | (46.05%) | (61.40%) | (56.36%) |
| Return on assets | (44.61%) | (54.77%) | (48.04%) |
| Return on invested capital | (1,100.93%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack